Companies
About
News
Contact
EN
FI
En
Link 1
Link 2
Link 3
News
All
Press
Events
Announcements
News
DevCo closes a 616 MEUR long-term single-asset investment vehicle for Medix Biochemica
3.9.2024
DevCo Partners’ application period for 2025 internships is now open
Announcements
18.8.2024
Medix Biochemica Appoints Lonnie Shoff, Seasoned Healthcare Executive to its Board of Directors
8.7.2024
DevCo strengthens its team – Otto Saaranto to join as Investment Professional
Announcements
13.5.2024
Sustainability report for 2023 is published
Announcements
2.5.2024
DevCo strengthens its team – Timo Ihamuotila new Senior Advisor
Announcements
18.3.2024
Vexve Armatury Group companies join their forces under the Vexve brand
News
1.2.2024
Vexve Armatury Group Appoints Paul Gustavsson as New Chief Executive Officer
News
5.12.2023
Medix Biochemica expands its infectious diseases antibody offering through the acquisition of ViroStat
10.11.2023
Jonas Geust Becomes Bluefors CEO
5.10.2023
Linda Pålsson Appointed as Non-executive Director at Vexve Armatury Group Oy
News
28.9.2023
DevCo Partners’ application period for 2024 internships is now open
Announcements
18.8.2023
Bluefors to acquire its distributor Rockgate, establishing direct presence in the Japanese cryogenics technology market
News
25.5.2023
Bluefors to acquire Cryomech, creating a global leader in the ultra-low temperature cooling technology market
News
28.2.2023
Bluefors’ technology featured on the cover of TIME magazine
News
16.2.2023
Nick Adcock Appointed as Non-executive Director at Vexve Armatury Group Oy
News
7.9.2022
Medix Biochemica Appoints Dr. Michele Pedrocchi to its Board of Directors
1.9.2022
DevCo strengthens its team – Lennart Sjöblom to join as Investment Professional and Heli Leskinen as CFO
Announcements
1.8.2022
Medix Biochemica broadens its capabilities in diagnostic base matrices through the acquisition of Bioresource Technology
20.6.2022
Vexve Armatury Group strengthens its position in DACH region by acquiring Armatury Group GmbH
News
21.4.2022
Medix Biochemica expands its molecular diagnostics business through the acquisition of myPOLS Biotec
1.2.2022
DevCo closes its next long-term single-asset fund at €260m
15.12.2021
DevCo strengthens its team – Vanechka Patel new Investment Professional
Announcements
17.11.2021
DevCo strengthens its team – Outi Saari new Investment Professional
Announcements
16.8.2021
Medix Biochemica expands its monoclonal antibody offering through the acquisition of Diaclone
13.7.2021
Kari Lehtinen appointed as the new Chairman of the Board of Vexve Armatury Group
News
30.6.2021
DevCo strengthens its team – Heini Mänttäri new Investment Professional
Announcements
7.6.2021
DevCo’s partner and Chairman Matti Alahuhta joins the board of Kasvuryhmä
11.5.2021
DevCo to support Bluefors’ next growth phase
Announcements
21.4.2021
DevCo strengthens its team – Vella Kimpimäki new Finance Manager
31.3.2021
Article by DevCo's Otto Kukkonen featured in Yrityskatsaus magazine of The Ministry of Economic Affairs and Employment in Finland
22.2.2021
Column by Teemu Alahuhta featured in Perheyrityslehti
5.1.2021
Kari Lehtinen and Markku Simula Appointed as Non-executive Directors at Vexve Armatury Group
News
6.11.2020
DevCo continues as a business partner for Family Business Network Finland at least until 2022
25.9.2020
Vexve Armatury Group strengthens its position in petrochemical sector by acquiring German specialized valve supplier ZMK Technologies GmbH
News
5.6.2020
Medix Biochemica broadens product portfolio and further expands U.S. presence through acquisition of EastCoast Bio
5.6.2020
Medix Biochemica expands to Drugs of Abuse antibody and antigen manufacturing through acquisition of Biostride Inc.
5.6.2020
DevCo launches DevCo Academy - a top management training program
23.12.2019
Vexve Armatury Group featured in Kauppalehti
2.12.2019
Medix Biochemica expands to biomaterials for IVD industry through acquisition of Lee Biosolutions
18.11.2019
DevCo Partners strengthens its investor base by raising €180m of long-term commitments for its next platform investment
14.11.2019
Steve Ferguson appointed new CEO of Medix Biochemica
15.10.2019
DevCo has signed an agreement to acquire the leading Czech industrial valve manufacturer ARMATURY Group
News
21.8.2019
Medix Biochemica participates in the Annual Scientific Meeting & Clinical Lab Expo
21.5.2019
DevCo strengthens its team – Juhani Laakso new Partner
Announcements
17.5.2019
DevCo featured in Perheyrityslehti
18.3.2019
What to take into account during a generational change at a company?
18.3.2019
”Uusia suomalaisia suuryrityksiä rakentamassa”
23.1.2019
DevCo strengthens its team – Johannes Vanne new Associate
Announcements
18.10.2018
DevCo Partners to accelerate growth of Medix Biochemica
Announcements
1.2.2018
DevCo strengthens its team – Matias Karioja new Associate
Announcements
20.6.2017
DevCo Partners to accelerate growth of Vexve
News
30.6.2016
DevCo Partners strengthens its investor base
Announcements
14.3.2016
Devco Partners to support growth of medium-sized companies
News
16.6.2014